Neogen (NEOG) Net Cash Flow Growth (5y) (2015 - 2026)
Neogen (NEOG) Net Cash Flow Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.85 Bn | 176.55 Bn | 6.27 Bn |
| 2 | Stryker | 128.90 Bn | 126.02 Bn | 3.81 Bn |
| 3 | Medtronic | 108.55 Bn | 99.33 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.56 Bn | 67.10 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.24 Bn | 44.57 Bn | 1.29 Bn |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.15 Bn | 25.87 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - |
| 9 | Koninklijke Philips | 24.75 Bn | 21.63 Bn | 2.07 Bn |
| 10 | Neogen | 2.06 Bn | 1.90 Bn | 99.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 18.16% |
| Nov 30, 2025 | -32.62% |
| Aug 31, 2025 | 29.69% |
| May 31, 2025 | -16.04% |
| Feb 28, 2025 | 3.53% |
| Nov 30, 2024 | 19.25% |
| Aug 31, 2024 | -37.78% |
| May 31, 2024 | 16.85% |
| Feb 29, 2024 | -35.26% |
| Nov 30, 2023 | 66.92% |
| Aug 31, 2023 | -2.54% |
| May 31, 2023 | 87.96% |
| Feb 28, 2023 | -33.19% |
| Nov 30, 2022 | -22.24% |
| Aug 31, 2022 | 40.90% |
| May 31, 2022 | -33.73% |
| Feb 28, 2022 | 22.40% |
| Nov 30, 2021 | -27.78% |
| Aug 31, 2021 | -15.49% |
| May 31, 2021 | 15.85% |